Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Business of developing a pipeline of allogeneic CAR-T cell therapies2.02M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States32.77M95.05%
Rest of world1.71M4.95%